Valuation metrics show that Corsair Gaming, Inc. may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of CRSR, demonstrate its potential to outperform the market.
Similarly, Why does CRSR drop?
That’s what happened to Corsair Gaming ( CRSR -2.99% ) after its third-quarter earnings report on Tuesday. Supply chain issues pinched Corsair Gaming’s sales, causing revenue to drop 14% year over year.
Is CRSR a long term investment? Thanks to CRSR becoming a short-selling target, investors stand to benefit from a possible short squeeze, as well as the strong business fundamentals that have been laid out by the company. According to The Street, Corsair seems to be a good long-term investment.
Thereof, Who is selling CRSR?
MAJOROS GEORGE L. JR. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC).
…
Number of Insider Shares Traded.
| INSIDER TRADE | 3 MONTHS | 12 MONTHS |
|---|---|---|
| Net Activity | 164,696 | (23,917,588) |
Is CRSR a good company?
CRISPR Therapeutics AG – Hold
Valuation metrics show that CRISPR Therapeutics AG may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of CRSP, demonstrate its potential to outperform the market. It currently has a Growth Score of B.
Is CRSR in the Russell 2000?
(CRSR) exposure | ETF.com.
…
ETFs with the most CRSR shares.
| Ticker | Fund Name | # OF SHARES |
|---|---|---|
| IJR | iShares Core S&P Small-Cap ETF | 2.33M |
| IWM | iShares Russell 2000 ETF | 630.96K |
Who owns CRSR?
Top 10 Owners of Corsair Gaming Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 3.40% | 3,210,361 |
| BlackRock Fund Advisors | 1.77% | 1,671,240 |
| SignatureFD LLC | 0.82% | 773,138 |
| Sculptor Capital LP | 0.71% | 667,500 |
How much of Corsair does Eagle Tree own?
Corsair Gaming is not owned by hedge funds. EagleTree Capital, LP is currently the company’s largest shareholder with 59% of shares outstanding. This implies that they have majority interest control of the future of the company. With 2.9% and 2.8% of the shares outstanding respectively, BlackRock, Inc.
Is NIO a buy Zacks?
How good is it? See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank.
…
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.93% |
| 2 | Buy | 18.44% |
| 3 | Hold | 9.99% |
| 4 | Sell | 5.61% |
Is Crispr a good investment?
Yes, CRISPR Therapeutics boasts explosive upside potential, but it also comes with a decent amount of risk, more so than many investors can handle.
Does Crispr make money?
In 2021, Vertex acquired the rights to 60% of the profits from sales of CRISPR Therapeutics gene-editing therapy CTX001 for up to $1.1 billion, pending regulatory approval.
How many shares of CRSR are there?
Share Statistics
| Avg Vol (3 month) 3 | 1.38M |
|---|---|
| Shares Outstanding 5 | 94.34M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 37.05M |
| % Held by Insiders 1 | 3.41% |
What companies does Corsair own?
CORSAIR also includes subsidiary brands Elgato, which provides premium studio equipment and accessories for content creators, SCUF Gaming, which builds custom-designed controllers for competitive gamers, and ORIGIN PC, a builder of custom gaming and workstation desktop PCs and laptops.
Is Eagle Tree selling Corsair?
Through several of its subsidiaries, EagleTree, which bought a majority share in Corsair in July 2017 in a deal valued at $525M, and its co-managing partners George Majoros and Anup Bagaria are offering 7,135,000 of Corsair’s common stock.
Is ETSY a buy Zacks?
See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank.
…
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.93% |
| 2 | Buy | 18.44% |
| 3 | Hold | 9.99% |
| 4 | Sell | 5.61% |
What is a good price for nio stock?
NIO Inc (NYSE:NIO)
The 29 analysts offering 12-month price forecasts for NIO Inc have a median target of 32.97, with a high estimate of 86.67 and a low estimate of 24.11. The median estimate represents a +67.81% increase from the last price of 19.65.
What does Zacks say about NIO stock?
NIO 20.36 -1.32(-6.09%)
Zacks Investment Research is releasing its prediction for NIO based on the 1-3 month trading system that nearly triples the S&P 500.
Who owns CRISPR stock?
Top 10 Owners of CRISPR Therapeutics AG
| Stockholder | Stake | Shares owned |
|---|---|---|
| Capital Research & Management Co. … | 4.66% | 3,591,160 |
| Loomis, Sayles & Co. LP | 1.71% | 1,316,123 |
| T. Rowe Price Associates, Inc. (I… | 1.42% | 1,090,813 |
| Ecor1 Capital LLC | 1.40% | 1,077,483 |
Who owns CRISPR patent?
CRISPR Cas9 (white) uses Guide RNA to locate and cut the Target DNA sequence. Source: WikiMedia Now, companies like DowDuPont, MilliporeSigma, and Cellectis all own CRISPR-Cas9 patents.
Will Vertex buy CRISPR?
Vertex Is Buying Majority Rights to Gene-Editing Therapy From CRISPR Therapeutics. The biotech firm Vertex Pharmaceuticals is paying $900 million to CRISPR Therapeutics for rights to 60% of the profits from sales of a gene-editing therapy called CTX001.
Join TheMoney.co community and don’t forget to share this post !
